biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by wesdevrieson Mar 05, 2014 12:39pm

182 Views

Post# 22283687

RE:A Change in Plans and An Apology

Your car goes where your eyes go and one of the all-time greats said it best!

Focus on the road; not on the wall"! ~ Mario Andretti

There's always going to be idiots who will always tears down someone else’s hard work. For you "$hitheads", a few words of advice; the world now, more than ever needs people who contribute their gifts and share their work and ideas...no matter what the venue. Having to do that takes courage and that can be tough. We need to support the people who display that courage. So, are you a detractor or a contributor?

JD, ignore the boos, they usually always come from the cheap seats!

Cheers my friend!

wdv

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario